Murthy Chamarthy - Android Applications by Murthy Chamarthy
Barcelona Clinic Liver Cancer (BCLC) staging is a classification and treatment algorithm for hepatocellular carcinoma based on tumor characteristics and extent, performance status, stage of liver disease and Child-Pugh class, and other associated co-morbi
Free AppThis application provides a quick and easy reference to calculate the required volume of Gadolinium based contrast agents for MRI scan. User selects the contrast agent type and provides the body weight to calculate the administration volume. This applicat
Free AppMedical devices in interventional radiology, an application developed by Jorge Lopera, M.D & Murthy Chamarthy, M.D., provides step by step instructions on how to use the various devices during interventional radiology procedures. The application is suppor
Free AppMedRads provides a quick and easy reference for commonly used medications in Radiology. User can perform a keyword search for a particular medication or browse through the broader categories. This application would be particularly helpful for residents...
Free AppChild-Pugh (CP) classification was originally designed to determine the risk of portocaval shunt surgery in cirrhotic patients. CP classification provides mortality risk with abdominal surgery, survival rates and a likelihood of developing complications..
Free AppHong Kong Liver Cancer (HKLC) staging system is a classification and treatment algorithm for hepatocellular carcinoma based on tumor characteristics and extent, performance status, stage of liver disease and Child-Pugh class, and other associated co-morbi
Free AppVIR MedBASE provides a quick and easy reference for commonly used medications in Vascular and Interventional Radiology. User can perform a keyword search for a particular medication or browse through the procedure categories. This application would be...
Free AppModel for end-stage liver disease score is a model based on serum bilirubin, creatinine, and INR and is useful to predict the three month mortality risk in patients with chronic liver disease. It was initially developed for predicting the mortality subseq
Free App